Company / EPS (Diluted)
FENNEC PHARMACEUTICALS INC. EPS (Diluted) History
FY2014-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest EPS (Diluted)
-$0.02
FY2025
5-year range
-$0.90 / -$0.02
FY2021-FY2025
Trend
+96.7%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
EPS (Diluted) has fluctuated over the past 10 years, ranging from $-0.90 in FY2023 to $0.17 in FY2014.
Based on SEC 10-K filings.
-0.02 in FY2025.
Improved from $-0.90 to $-0.02 over the past 2 years.
EPS (Diluted) over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, eps (diluted) increased 96.7% year-over-year.
- Peak eps (diluted) was recorded in FY2014.
- Lowest eps (diluted) in the period was in FY2023.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | EPS (Diluted)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$0.02 | +96.7% |
| FY2024 | -$0.60 | +33.3% |
| FY2023 | -$0.90 | -18.4% |
| FY2021 | -$0.76 | -46.2% |
| FY2019 | -$0.52 | -10.6% |
| FY2018 | -$0.47 | -113.6% |
| FY2017 | -$0.22 | -266.7% |
| FY2016 | -$0.06 | +72.7% |
| FY2015 | -$0.22 | -229.4% |
| FY2014 | $0.17 | +181.0% |
As of FY2025 · SEC 10-K Annual Filings · Updated Jun 24, 2026